Executive 10b5-1 Sales Reported
Reported 10b5-1 sales by an executive of QLYS.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Reported 10b5-1 sales by an executive of QLYS. The filing lists sales of 1,627 shares on 05/19/2026 for $162,976.00 and 1,031 shares on 06/02/2026 for $115,128.37. It also lists 965 shares tied to an Employee Stock Purchase Plan dated 02/15/2022.
Insights
Rule 144/10b5-1 sale filings documenting recent executive dispositions.
The filing lists two 10b5-1 sales by Joo Mi Kim: 1,627 shares on 05/19/2026 and 1,031 shares on 06/02/2026, with cash proceeds shown. It also references 965 shares associated with an Employee Stock Purchase Plan dated 02/15/2022.
These notices are procedural disclosures under resale rules; cash‑flow treatment and any trading-plan terms beyond the 10b5-1 label are not shown in the excerpt.
Key Figures
Key Terms
10b5-1 regulatory
Employee Stock Purchase Plan financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What 10b5-1 sales did QLYS report?
Who is the reporting person for these QLYS transactions?
Do these entries state who received the proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.